Author
Listed:
- Hiroshi Kobayashi
(Faculty of Medicine, The University of Tokyo)
- Song Ho Chang
(Faculty of Medicine, The University of Tokyo)
- Daisuke Mori
(Faculty of Medicine, The University of Tokyo
Faculty of Medicine, The University of Tokyo)
- Shozo Itoh
(Faculty of Medicine, The University of Tokyo)
- Makoto Hirata
(Faculty of Medicine, The University of Tokyo)
- Yoko Hosaka
(Faculty of Medicine, The University of Tokyo
Faculty of Medicine, The University of Tokyo)
- Yuki Taniguchi
(Faculty of Medicine, The University of Tokyo)
- Keita Okada
(Faculty of Medicine, The University of Tokyo)
- Yoshifumi Mori
(Faculty of Medicine, The University of Tokyo)
- Fumiko Yano
(Faculty of Medicine, The University of Tokyo
Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo)
- Ung-il Chung
(Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo)
- Haruhiko Akiyama
(Gifu University)
- Hiroshi Kawaguchi
(Faculty of Medicine, The University of Tokyo
Tokyo Shinjuku Medical Center, Japan Community Health Care Organization)
- Sakae Tanaka
(Faculty of Medicine, The University of Tokyo)
- Taku Saito
(Faculty of Medicine, The University of Tokyo
Faculty of Medicine, The University of Tokyo)
Abstract
In vitro studies have shown that Rela/p65, a key subunit mediating NF-κB signalling, is involved in chondrogenic differentiation, cell survival and catabolic enzyme production. Here, we analyse in vivo functions of Rela in embryonic limbs and adult articular cartilage, and find that Rela protects chondrocytes from apoptosis through induction of anti-apoptotic genes including Pik3r1. During skeletal development, homozygous knockout of Rela leads to impaired growth through enhanced chondrocyte apoptosis, whereas heterozygous knockout of Rela does not alter growth. In articular cartilage, homozygous knockout of Rela at 7 weeks leads to marked acceleration of osteoarthritis through enhanced chondrocyte apoptosis, whereas heterozygous knockout of Rela results in suppression of osteoarthritis development through inhibition of catabolic gene expression. Haploinsufficiency or a low dose of an IKK inhibitor suppresses catabolic gene expression, but does not alter anti-apoptotic gene expression. The biphasic regulation of chondrocytes by Rela contributes to understanding the pathophysiology of osteoarthritis.
Suggested Citation
Hiroshi Kobayashi & Song Ho Chang & Daisuke Mori & Shozo Itoh & Makoto Hirata & Yoko Hosaka & Yuki Taniguchi & Keita Okada & Yoshifumi Mori & Fumiko Yano & Ung-il Chung & Haruhiko Akiyama & Hiroshi Ka, 2016.
"Biphasic regulation of chondrocytes by Rela through induction of anti-apoptotic and catabolic target genes,"
Nature Communications, Nature, vol. 7(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms13336
DOI: 10.1038/ncomms13336
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms13336. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.